XORTX Therapeutics Inc. (XRTX) Financials
All currency values in $ millions unless otherwise noted
Scroll
| Income Statement | TTM | DEC 2025 | DEC 2024 | DEC 2023 | DEC 2022 | DEC 2021 |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$4 | -$3 | -$4 | -$6 | -$7 | -$2 |
| Non-Operating | ||||||
| Net Interest Expense | — | — | — | — | $0 | -$0 |
| Net Income | ||||||
| Net Income | -$4 | -$3 | -$3 | -$2 | -$5 | -$1 |
| Per Share Data | ||||||
| Revenue Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS (Basic) | -$2.89 | -$2.80 | -$1.15 | -$1.09 | -$4.71 | -$1.20 |
| EPS (Diluted) | -$2.89 | -$2.80 | -$1.15 | -$1.09 | -$4.71 | -$1.20 |
| Shares Outstanding | 1.6M | 948,680 | 2.9M | 2.0M | 1.2M | 927,804.69 |
XORTX Therapeutics (XRTX) financials: revenue, profit and margins
XORTX Therapeutics (XRTX) generated about $0.00 in revenue and -$4 million in net income over the trailing twelve months. Figures are from company filings; this is analysis, not investment advice.
Frequently asked
What is XORTX Therapeutics's (XRTX) revenue?+
XORTX Therapeutics generated about $0.00 in revenue over the trailing twelve months. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.
Is XORTX Therapeutics profitable?+
XORTX Therapeutics reported about -$4 million in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.
Related stocks: Biotechnology
Spot a number that looks wrong?
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.